Table 2.
Salmonella Typhimurium strains belonging to different phage types show identical CRISPR/CRISPOL type
| Phage type | Isolate ID (source) | Lab | Accession Number | CRISPR type | CRISPOL type | Reference |
|---|---|---|---|---|---|---|
| CRISPR/CRISPOL type among phage types DT8 and DT30 of S. Typhimurium | ||||||
| DT8 | M18-2003 (Control DT8) | NSSLRL | aTraces-0jdDfGp (PRJEB18673) | 1069 | 6 | This study |
| DT8 | DT8 (Clinical isolate) | Wellcome Trust Sanger Institute | bTraces-0CerOby (ERS007592) | 1069 | 6 | [2] |
| DT8 | S81-848 (Veterinary isolate) | Institut Pasteur | Traces-0PArkjM | 1069 | 6 | Enterobase |
| DT8 | MS150057 (Clinical isolate) | NSSLRL | Traces-0xVpmwI | 2260 | 708 | Enterobase |
| DT30 | MS57 (Control DT30) | NSSLRL | aTraces-0aYyWix (ERS640854) | 812 | 250 | [8] |
| DT8 | M12-2001 (Control DT8) | NSSLRL | aTraces-0Jyulvx (PRJEB18673) | 812 | 250 | This study |
| DT8 | M15-2006 (Control DT8) | NSSLRL | aTraces-0WxCKWi (PRJEB18673) | 812 | 250 | This study |
| DT8 | MS32 (Control DT8) | NSSLRL | aTraces-0dPdGho (PRJEB18673) | 812 | 250 | This study |
| CRISPR/CRISPOL type among phage types DT104, DT104b and U302 of S. Typhimurium | ||||||
| DT104b | MS130531 (Control DT104b) | NSSLRL | aTraces-0ptnSId (PRJEB18673) | 12 | 21 | This study |
| U302 | M18-2006 (Control U302) | NSSLRL | aTraces-0rRUdtU (PRJEB18673) | 12 | 21 | This study |
| DT104 | TM75-339 (No data) | Institut Pasteur | Traces-0dpLsNp | 12 | 21 | Enterobase |
| DT104 | MS150098 (Clinical isolate) | NSSLRL | Traces-0VNfjhC | 12 | 21 | Enterobase |
| DT104 | MS150095 (Clinical isolate) | NSSLRL | Traces-0ohRXMQ | 12 | 21 | Enterobase |
| DT104b | MS150159 (Clinical isolate) | NSSLRL | Traces-0mdEaBO | 12 | 21 | Enterobase |
| DT104b | MS150253 (Clinical isolate) | NSSLRL | Traces-0VfHkWp | 7556 | 315 | Enterobase |
| DT104 | MS150005 (Clinical isolate) | NSSLRL | Traces-0ehJIGG | 5000 | 168 | Enterobase |
| CRISPR/CRISPOL type among phage types DT99, DT56, U319 and DT40 of S. Typhimurium | ||||||
| DT99 | DT99 (Clinical isolate) | Wellcome Trust Sanger Institute | bTraces-0fQeupq (ERS007596) | 7433 | 14 | [2] |
| DT56 | DT56 (Clinical isolate) | Wellcome Trust Sanger Institute | bTraces-0WirVGQ (ERS007588) | 7433 | 14 | [2] |
| U319 | U319 (Clinical isolate) | Wellcome Trust Sanger Institute | bTraces-0nXusuL (ERS007613) | 7433 | 14 | [2] |
| DT40 | S05-2864 (Clinical isolate) | Institut Pasteur | Traces-0PxGcXB | 7433 | 14 | Enterobase |
| DT40 | M20-2006 (Control isolate) | NSSLRL | aTraces-0rGCwUc (PRJEB18673) | 9520 | 1637 | This study |
| DT40 | M19-2003 (Control isolate) | NSSLRL | aTraces-0nxmoMB (PRJEB18673) | 9519 | 1636 | This study |
| DT40 | CQ 40 | Institut Pasteur | Traces-0LSHwEV | 745 | 18 | Enterobase |
| CRISPR/CRISPOL type among phage types DT120, DT7a, DT193 and untypable strains of S. Typhimurium | ||||||
| DT120 | S02-3776 (Clinical isolate) | Institut Pasteur | Traces-0yQDdlW | 9921 | 1759 | Enterobase |
| DT120 | 07_2198 (No Data) | Institut Pasteur | Traces-0pKTfCi | 9911 | 1753 | Enterobase |
| DT120 | M16-2000 (Control DT120) | NSSLRL | aTraces-0fEcWgz (PRJEB18673) | 9510 | 1428 | Enterobase |
| DT7a | MS120840 (Control DT7a) | NSSLRL | aTraces-0psYyDm (PRJEB18673) | 9510 | 1428 | Enterobase |
| DT120 | S/20160374 (Clinical isolate) | SSSCDRL | Traces-0CeRVgg | 322 | 1 | Enterobase |
| DT120 | S/20160407 (Clinical isolate) | SSSCDRL | Traces-0agMeAc | 322 | 1 | Enterobase |
| DT20a | MS150110 (Clinical isolate) | NSSLRL | Traces-0isgxxB | 322 | 1 | Enterobase |
| Untypable | MS150097 (Clinical isolate) | NSSLRL | Traces-0VSlIab | 322 | 1 | Enterobase |
| DT193 | MS150007 (Clinical isolate) | NSSLRL | Traces-0vpTyIh | 322 | 1 | Enterobase |
| DT193 | MS150252 (Clinical isolate) | NSSLRL | Traces-0WAKQQZ | 317 | 2 | Enterobase |
| CRISPR/CRISPOL type among phage types DT12, DT3 and DT193a of S. Typhimurium | ||||||
| DT12 | DT12 (Clinical isolate) | Wellcome Trust Sanger Institute | bTraces-0kmZJki (ERS007564) | 5268 | 19 | [2] |
| DT12 | S02-2651 (Clinical isolate) | Institut Pasteur | Traces-0FbQprS | 774 | 46 | Enterobase |
| DT3 | S81-482 (Clinical isolate) | Institut Pasteur | Traces-0pUCktc | 5268 | 19 | Enterobase |
| DT3 | S81-531 (Veterinary isolate) | Institut Pasteur | Traces-0pGWuNa | 539 | 13 | Enterobase |
| DT193a | MS120454 (Clinical isolate) | NSSLRL | Traces-0hfCzzz | 774 | 46 | Enterobase |
| CRISPR/CRISPOL type among phage types DT135, DT191a and RDNC strains of S. Typhimurium | ||||||
| DT135 | DT135 (Clinical isolate) | Wellcome Trust Sanger Institute |
bTraces-0xEkcLV ERS007567 |
5753 | 396 | [2] |
| DT135 | MS150100 (Clinical isolate) | NSSLRL | Traces-0fqzVBN | 3247 | 66 | Enterobase |
| DT135 | MS150112 (Clinical isolate) | NSSLRL | Traces-0TpmttL | 91 | 4 | Enterobase |
| DT135 | MS150180 (Clinical isolate) | NSSLRL | Traces-0FksMUv | 91 | 4 | Enterobase |
| DT191a | DT191a (Clinical isolate) | Wellcome Trust Sanger Institute |
bTraces-0KhAoGt ERS007574 |
91 | 4 | [2] |
| RDNC | MS150102 (Clinical isolate) | NSSLRL | Traces-0bmnIRV | 91 | 4 | Enterobase |
| RDNC | MS150230 (Clinical isolate) | NSSLRL | Traces-0vTHNcg | 91 | 4 | Enterobase |
| RDNC | MS150009 (Clinical isolate) | NSSLRL | Traces-0Zipaoz | 9404 | 1614 | Enterobase |
aAccession Numbers in Enterobase of control phage types of S. Typhimurium sequenced in this study. The Accession Number in ENA is also provided
bAccession Numbers in Enterobase of clinical isolates of S. Typhimurium used in this study. The Accession Number in ENA is also provided